Table 3.
CAC progression | ||||||
---|---|---|---|---|---|---|
Overall | Non-diabetes | Diabetes | ||||
OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | |
AIP (per-0.1 unit increase) | 1.04 (1.03 − 1.06) | < 0.001 | 1.04 (1.02 − 1.06) | < 0.001 | 1.03 (0.99 − 1.08) | 0.100 |
TyG index (per-1 unit increase) | 1.42 (1.31 − 1.55) | < 0.001 | 1.32 (1.19 − 1.46) | < 0.001 | 1.33 (1.10 − 1.60) | 0.003 |
HbA1C (per-1% increase) | 1.25 (1.18 − 1.34) | < 0.001 | 0.99 (0.85 − 1.15) | 0.850 | 1.19 (1.08 − 1.32) | 0.001 |
P values for interaction of diabetes with AIP, TyG index, and HbA1C level were 0.033, 0.006, and 0.543, respectively
Analysis was adjusted for age, sex, hypertension, hyperlipidemia, obesity, current smoking, serum creatinine level, baseline CACS, and interscan periods
AIP atherogenic index of plasma, CAC coronary artery calcification, CACS coronary artery calcium score, CI confidence interval, OR odds ratio, HbA1C hemoglobin A1C, TyG triglyceride glucose